FDA Inspection 606967 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3002733956

The FDA completed an inspection of Fresenius Kabi USA, LLC on September 25, 2009 in Lake Zurich, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lake Zurich, IL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113321 CFR 211.25(a)GMP Training Frequency